Forty Seven Inc is a clinical-stage immuno-oncology company. It is engaged in developing novel checkpoint therapies to activate macrophages and help the ...

Sanofi has offered to acquire all the outstanding shares of Synthorx for $68 per share in cash, a premium of almost 172% to ...

In premarket trading this morning, ArQule (ARQL) soared 102.8%, near $19.60. This stock closed at 9.66$ on Friday afternoon. It spike is ...